The scent fingerprint of hepatocarcinoma: in-vitro metastasis prediction with volatile organic compounds (VOCs)

Background: Hepatocellular carcinoma (HCC) is a common and aggressive form of cancer. Due to a high rate of postoperative recurrence, the prognosis for HCC is poor. Subclinical metastasis is the major cause of tumor recurrence and patient mortality. Currently, there is no reliable prognostic method of invasion. Aim: To investigate the feasibility of fingerprints of volatile organic compounds (VOCs) for the in-vitro prediction of metastasis. Methods: Headspace gases were collected from 36 cell cultures (HCC with high and low metastatic potential and normal cells) and analyzed using nanomaterial-based sensors. Predictive models were built by employing discriminant factor analysis pattern recognition, and the classification success was determined using leave-one-out cross-validation. The chemical composition of each headspace sample was studied using gas chromatography coupled with mass spectrometry (GC-MS). Results: Excellent discrimination was achieved using the nanomaterial-based sensors between (i) all HCC and normal controls; (ii) low metastatic HCC and normal controls; (iii) high metastatic HCC and normal controls; and (iv) high and low HCC. Several HCC-related VOCs that could be associated with biochemical cellular processes were identified through GC-MS analysis. Conclusion: The presented results constitute a proof-of-concept for the in-vitro prediction of the metastatic potential of HCC from VOC fingerprints using nanotechnology. Further studies on a larger number of more diverse cell cultures are needed to evaluate the robustness of the VOC patterns. These findings could benefit the development of a fast and potentially inexpensive laboratory test for subclinical HCC metastasis.

[1]  Ulrike Tisch,et al.  Volatile Organic Compounds in Exhaled Breath as Biomarkers for the Early Detection and Screening of Lung Cancer , 2012 .

[2]  H. Haick,et al.  Detection of asymptomatic nigrostriatal dopaminergic lesion in rats by exhaled air analysis using carbon nanotube sensors. , 2012, ACS chemical neuroscience.

[3]  H. Haick,et al.  Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. , 2011, ACS chemical neuroscience.

[4]  Radu Ionescu,et al.  Nanoarray of polycyclic aromatic hydrocarbons and carbon nanotubes for accurate and predictive detection in real-world environmental humidity. , 2011, ACS nano.

[5]  H. Haick,et al.  Utility of Resistance and Capacitance Response in Sensors Based on Monolayer-Capped Metal Nanoparticles , 2011 .

[6]  H. Haick,et al.  Diagnosis of head-and-neck cancer from exhaled breath , 2011, British Journal of Cancer.

[7]  Ulrike Tisch,et al.  Classification of breast cancer precursors through exhaled breath , 2011, Breast Cancer Research and Treatment.

[8]  Yang Jiang,et al.  Hepatoma cell line HepG2.2.15 demonstrates distinct biological features compared with parental HepG2. , 2011, World journal of gastroenterology.

[9]  D. Xie,et al.  Sorafenib suppresses postsurgical recurrence and metastasis of hepatocellular carcinoma in an orthotopic mouse model , 2011, Hepatology.

[10]  Ulrike Tisch,et al.  Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing , 2010 .

[11]  H. Haick,et al.  Carbon Nanotube/Hexa‐peri‐hexabenzocoronene Bilayers for Discrimination Between Nonpolar Volatile Organic Compounds of Cancer and Humid Atmospheres , 2010, Advanced materials.

[12]  Ulrike Tisch,et al.  Nanomaterials for cross-reactive sensor arrays , 2010 .

[13]  Qiu-an Wang,et al.  Synthesis and Cytotoxicity of Novel Benzofuran Neolignan Derivatives. , 2010 .

[14]  Tao Qin,et al.  The Screening of Volatile Markers for Hepatocellular Carcinoma , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  H. Haick,et al.  Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors , 2010, British Journal of Cancer.

[16]  Zhao-You Tang,et al.  Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects , 2010, Clinical Cancer Research.

[17]  S. Manna,et al.  Novel Derivative of Benzofuran Induces Cell Death Mostly by G2/M Cell Cycle Arrest through p53-dependent Pathway but Partially by Inhibition of NF-κB* , 2010, The Journal of Biological Chemistry.

[18]  Hossam Haick,et al.  Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. , 2009, Small.

[19]  H. Haick,et al.  Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.

[20]  Kevin M. Ryan,et al.  p53 and metabolism , 2009, Nature Reviews Cancer.

[21]  I. Horváth,et al.  Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.

[22]  H. Haick,et al.  Spongelike structures of hexa-peri-hexabenzocoronene derivatives enhance the sensitivity of chemiresistive carbon nanotubes to nonpolar volatile organic compounds of cancer. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[23]  H. Haick,et al.  Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. , 2008, Nano letters.

[24]  K. Chan,et al.  Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.

[25]  Chunhui Deng,et al.  Investigation of volatile biomarkers in liver cancer blood using solid-phase microextraction and gas chromatography/mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[26]  Ping Wang,et al.  A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.

[27]  Anton Amann,et al.  Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .

[28]  David Smith,et al.  Breath analysis: the approach towards clinical applications. , 2007, Mini reviews in medicinal chemistry.

[29]  Svetlana V. Ukraintseva,et al.  Cancer in rodents: does it tell us about cancer in humans? , 2005, Nature Reviews Cancer.

[30]  Yan Li,et al.  Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics , 2004, Journal of Cancer Research and Clinical Oncology.

[31]  R. Zeng,et al.  Proteome analysis of hepatocellular carcinoma cell strains, MHCC97‐H and MHCC97‐L, with different metastasis potentials , 2004, Proteomics.

[32]  Robert A. Weinberg,et al.  Comparative Biology of Mouse versus Human Cells: Modelling Human Cancer in Mice O P I N I O N , 2022 .

[33]  J. Brezmes,et al.  Quantitative analysis of NO2 in the presence of CO using a single tungsten oxide semiconductor sensor and dynamic signal processing. , 2002, The Analyst.

[34]  L. Qin,et al.  Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. , 2001, World journal of gastroenterology.

[35]  S. Ye,et al.  Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. , 2001, World journal of gastroenterology.

[36]  Jacques Ferlay,et al.  Estimating the world cancer burden: Globocan 2000 , 2001, International journal of cancer.

[37]  S. Ye,et al.  New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis , 1999, British Journal of Cancer.

[38]  D. Welch Technical considerations for studying cancer metastasis in vivo , 1997, Clinical & Experimental Metastasis.

[39]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis. , 1995, The American surgeon.

[40]  K. Pickard,et al.  The regulation of transaminative flux of methionine in rat liver mitochondria. , 1994, Archives of biochemistry and biophysics.

[41]  C. Kneepkens,et al.  The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.

[42]  I. Fidler,et al.  Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. Clowes memorial award lecture. , 1990, Cancer research.

[43]  Y. Morioka,et al.  Postoperative Recurrence of Hepatocellular Carcinoma , 1990, Annals of surgery.

[44]  H. J. O’neill,et al.  A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. , 1988, Clinical chemistry.

[45]  J. Davies,et al.  Molecular Biology of the Cell , 1983, Bristol Medico-Chirurgical Journal.

[46]  W. W. Daniel Applied Nonparametric Statistics , 1978 .

[47]  L. Zieve,et al.  Mercaptans and dimethyl sulfide in the breath of patients with cirrhosis of the liver. Effect of feeding methionine. , 1970, The Journal of laboratory and clinical medicine.

[48]  F. Wilcoxon Individual Comparisons by Ranking Methods , 1945 .

[49]  郑俊海,et al.  科技期刊稿件处理的精细化管理——《International Journal of Nanomedicine〉〉投稿体会 , 2014 .

[50]  H. Haick,et al.  Effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples. , 2012, ACS applied materials & interfaces.

[51]  Bo Li,et al.  [Comparison of the metastatic characteristics of HCCLM3 cells and SMCC-7721 cells in nude mice model]. , 2010, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

[52]  Chen Ze-xiong Establishing Human hepatoma model from subcutane to orthotopic transplantation with Bel-7402 cells in athymic mice and PTEN expression , 2007 .

[53]  Paul Okunieff,et al.  Past, present, and future of oxygen in cancer research. , 2005, Advances in experimental medicine and biology.

[54]  D. Parkin International variation , 2004, Oncogene.

[55]  S. Shott,et al.  Nonparametric Statistics , 2018, The Encyclopedia of Archaeological Sciences.

[56]  G. Preti,et al.  Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. , 1988, Journal of chromatography.

[57]  Y. Morioka,et al.  Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. , 1987 .

[58]  D. Woodfield Hepatocellular carcinoma. , 1986, The New Zealand medical journal.

[59]  S. Singer,et al.  The fluid mosaic model of the structure of cell membranes. , 1972, Science.